Sign up
Connect with Google
Or
Already registered? Login
By continuing, you agree to our Terms of Use and Privacy Policy.
Reset Password
Enter your new password
signin
Join Our New Letter
By Scott Smith
•
July 29, 2024
Notable Labs is revolutionizing cancer treatment with its innovative approach to combination therapy, which targets multiple cancer pathways simultaneously. Their Predictive Precision Medicine Platform (PPMP) leverages advanced data analysis and machine learning to identify the most effective drug combinations for individual patients. By using high-throughput screening and bio-simulation, Notable Labs accelerates drug development, reduces costs, and improves clinical trial success rates. This approach promises significant improvements in patient outcomes, particularly for pediatric leukemia, by providing personalized, effective treatments and minimizing side effects.
By Syeda Abeer Iqbal
•
July 29, 2024
Notable Labs is transforming pediatric leukemia treatment with its Predictive Precision Medicines Platform (PPMP), which boasts a 97% predictive precision. This platform rapidly identifies the most effective treatments for individual patients, significantly reducing the time and cost of cancer therapy. Notable Labs focuses on personalized medicine, combining high-throughput screening and machine learning to predict patient responses and tailor treatments accordingly. Their innovative approach has shown promising results in clinical validation studies, offering new hope for improving outcomes in pediatric leukemia.
By Kathleen Mackay
•
July 29, 2024
Notable Labs is transforming cancer treatment with its innovative combination therapy approach. By leveraging its Predictive Precision Medicine Platform (PPMP), Notable identifies optimal drug combinations tailored to individual patients. This methodology aims to reduce the development of resistant cancer cells and allows each drug to be used at its best dosage without intolerable side effects. The platform has shown impressive predictive accuracy in clinical trials, particularly for pediatric leukemia. Notable's commitment to precision medicine offers new hope for patients with high unmet medical needs, driving better treatment outcomes and enhancing quality of life.
By Ayushi Hisaria
•
July 29, 2024
Notable Labs' cutting-edge diagnostic technology, boasting a 95% prediction accuracy per a Stanford study, is set to revolutionize pediatric leukemia treatment by identifying the most effective therapies. Their mission centers on advancing precision diagnostics to enhance therapy efficacy for young patients. Utilizing high-throughput screening and machine learning, Notable's platform offers tailored treatment plans, significantly improving outcomes for rare and aggressive forms of leukemia. This approach holds promise for personalized medicine, ensuring each child receives optimal, life-saving care.
By Daniel Ferry
•
July 29, 2024
Notable Labs is a clinical-stage precision oncology company developing new cancer therapies identified by its Predictive Medicine Platform (PMP), today announced progress for the Phase 2 volasertib program following receipt of “Clearance to Proceed” from the FDA and agreement on the dosing plan for its Phase 2 clinical trial. With trial start-up activities launched in the first quarter of this year, Notable intends to initiate enrollment in the Phase 2 study for PMP-enabled development of volasertib for relapsed refractory (R/R) acute myeloid leukemia (AML) in the coming months.
July 27, 2024
This blog explores how nutrigenomics—the study of nutrition's impact on genes—is revolutionizing clinical trials. By tailoring diets based on genetic differences, researchers can enhance health outcomes and prevent diseases. Notable Labs is at the forefront of this innovation, integrating genetic insights into personalized nutrition. The blog also touches on the ethical considerations of this approach.
July 27, 2024
Patient registries are vital in clinical research, offering real-world data that enhances understanding of diseases and treatments. By including diverse patient populations, these registries provide comprehensive insights into disease trends and treatment outcomes, which are often missed in controlled clinical trials. This blog discusses the importance of patient registries, highlighting their benefits, challenges, and future potential in advancing medical research and improving patient care.
July 27, 2024
Epigenetics is transforming clinical research by uncovering how gene expression is regulated beyond DNA sequences. This blog explores mechanisms like DNA methylation and histone modification, which impact diseases such as cancer and neurodegenerative disorders. It highlights the potential of epigenetics in personalized medicine, offering new avenues for diagnostics and treatments. Discover the latest research trends and the promise of epigenetic therapies in revolutionizing healthcare.
July 27, 2024
AI is revolutionizing drug development by speeding up processes and reducing costs. It enhances target identification, drug discovery, and clinical trials through advanced data analysis and predictive modeling. This leads to more personalized and effective treatments. The blog also addresses challenges like data privacy and ethical concerns, highlighting AI's transformative potential in the pharmaceutical industry.
July 27, 2024
Recruiting participants for clinical trials is challenging, but social media is changing the game. Platforms like Facebook and Instagram enable researchers to target specific demographics, reaching a broader and more diverse audience quickly and cost-effectively. This blog explores how social media enhances recruitment efforts, the strategies for effective use, and the potential challenges involved.
© 2025
All Rights Reserved | Clinical Research Trends